ADIM
APH icon

Alpha DNA Investment Management’s Amphenol APH Stock Holding History

Alpha DNA Investment Management’s Portfolio APH Stock Details APH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,674
Closed -$811K – 23
2024
Q4 		$811K Sell
11,674
-688
-6% -$48.2K 0.31% 66
2024
Q3 		$806K Buy
12,362
+880
+8% +$57K 0.3% 75
2024
Q2 		$774K Buy
+11,482
New +$724K 0.3% 75

Other funds holding APH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Alpha DNA Investment Management's APH Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Amphenol (APH) in Q1 2025, closing a stake of 11,674 shares — an estimated $811K sold.

Alpha DNA Investment Management first reported a position in APH in Q2 2024 and held it in 3 quarters. The position peaked at $811K in Q4 2024. 1,424 funds tracked by Wall St. Rank hold APH as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Amphenol position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 11,674 Amphenol shares in Q1 2025, an estimated $811K.
  • Alpha DNA Investment Management first reported a position in Amphenol in Q2 2024 and held it in 3 quarters.
  • Alpha DNA Investment Management's Amphenol position peaked at $811K in Q4 2024.
  • 1,424 funds tracked by Wall St. Rank held Amphenol as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.